OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
55 hedge funds and large institutions have $154M invested in OncoMed Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$20.6M | |
| 2 | +$10.2M | |
| 3 | +$9.39M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.74M |
| 5 |
Primecap Management
Pasadena,
California
|
+$2.83M |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$2.22M | |
| 3 | -$1.76M | |
| 4 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
-$1.53M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.53M |